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SOLUTIONS FOR PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES
Mobilising society to implement solutions for 
non-communicable diseases
A BMJ series helps map the way towards better health and wellbeing for all
Non-communicable diseases (NCDs) constitute a major global health challenge ham-pering nations’ economic growth and sustainable devel-
opment. Nearly three quarters (71%) of all-
cause mortality worldwide is attributed to 
NCDs, resulting in 15 million people dying 
prematurely (between the ages of 30-69 
years) each year.1 The global burden of 
NCDs disproportionately affects low and 
middle income countries, where 75% of 
deaths from NCDs and over 85% of all pre-
mature NCD related deaths take place.2
The four major groups of NCDs—namely, 
cardiovascular diseases, cancer, chronic 
respiratory diseases, and diabetes—
account for over 80% of all NCD related 
deaths and share the same four main 
risk factors: tobacco use, harmful use of 
alcohol, unhealthy diets, and physical 
inactivity. Mental health and environmental 
determinants were recently added to the 
NCD agenda broadening its scope from 
four-by-four to five-by-five.
Risk factors for NCDs are influenced by 
socioeconomic determinants of health 
that exacerbate health inequalities, with 
the most vulnerable and marginalised 
groups hit hardest. Evidence is mounting 
of substantial human, social, and economic 
costs from NCDs. A report by the World 
Economic Forum and the Harvard School 
of Public Health estimated that cumulative 
output loss due to cardiovascular disease, 
chronic respiratory disease, cancer, 
diabetes and mental health in low and 
middle income countries will be more than 
$47tn (£36tn; €42tn).if national responses 
are not scaled up between 2011 and 2030.3 
However, low and middle income countries 
that implement available cost effective (best 
buy) interventions immediately will see a 
return of $7 per person by 2030 for every 
dollar invested.4
Recently, there has been a push to 
accelerate action against the threat of 
NCDs at both global and national levels. 
United Nations General Assembly high level 
meetings on the prevention and control of 
NCDs in 2011, 2014, and 2018 placed 
NCDs high on the global health policy 
agenda and reaffirmed the responsibility 
of governments to tackle the NCD crisis by 
developing adequate national multisectoral 
policy responses. The high level meetings 
also reiterated the importance of shared 
accountability by stakeholders across 
sectors to create an environment conducive 
to preventing and controlling NCDs.5
When heads of  state,  heads of 
government, and other high level 
representatives met in New York in 
September 2015 to launch the sustainable 
development goals (SDGs), NCDs (which 
were not included in the millennium 
development goals) were recognised as 
a major barrier to achieving key health 
related objectives. SDG target 3.4 is a 
commitment to reduce premature mortality 
from NCDs by a third by 2030 and enhance 
mental health and wellbeing.6 Other targets 
related to NCDs include strengthening 
policies to reduce the harmful use of 
alcohol, achieving universal health 
coverage, strengthening implementation of 
the World Health Organization’s Framework 
Convention on Tobacco Control, supporting 
research and development of vaccines and 
medicines for NCDs that primarily affect 
low and middle income countries, and 
providing access to affordable essential 
medicines and vaccines for NCDs.7
Despite the growing global interest 
in NCDs, progress has been insufficient 
because countries with limited resources 
struggle with weak health systems and 
poor national capacities, including 
technical expertise, research capacity, and 
surveillance and programme evaluation 
data. Governments find it particularly 
difficult  to maintain the political 
momentum generated by UN General 
Assembly meetings and translate those 
high level commitments into effective 
national action, despite the availability 
of evidence based and cost effective 
interventions for prevention and control 
of NCDs. There are many reasons for this, 
but some of the main challenges are listed 
in box 1.
The political landscape for NCDs is 
entering a critical period globally, but 
despite implementation challenges 
we see evidence of renewed political 
commitments and more buy-in from 
national governments. This series of 
articles on NCDs (www.bmj.com/NCD-
solutions) represents a timely collaboration 
between The BMJ and WHO and builds on 
the gathering momentum for global action. 
It provides an outlook on the challenges 
in the prevention and control of NCDs at 
national, regional, and global levels and 
highlights the need for multisectoral and 
multistakeholder policies and for health-
in-all and whole-of-society approaches to 
curb the epidemic. Authors from diverse 
settings—including policy experts from 
academia, WHO, other UN agencies, non-
governmental organisations, and business 
associations—suggest scalable solutions 
to accelerate the implementation of the 
commitments made in the three UN General 
Assembly high level meetings on NCDs.
The articles in this series cover the main 
issues in prevention and control of NCDs, 
including financing and partnership 
building,8 integration of NCDs into primary 
care,9 implementation research, social 
determinants of health,10 multisectoral 
action, nutrition and environmental 
influences,11 12 a life course approach,13 and 
the development cooperation. It provides a 
holistic perspective on current challenges 
Box 1: Barriers to implementation
• Lack of political will, leadership, commitment, capacity, and action
• Lack of specific policies and costed plans for NCD prevention and control
• Difficulty in priority setting among competing health programmes and adequate and 
predictable allocation of resources
• Effect of countervailing economic, commercial, and market forces
• Insufficient technical and operational capacity
• Insufficient (domestic and international) financing4
• Difficulty of engaging with a highly fragmented and unregulated private sector
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and possible solutions towards meeting the 
global NCD targets and improving health 
worldwide by 2030.
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